A comparison of total and free β‐HCG assays in Down syndrome screening
- 1 June 1993
- journal article
- research article
- Published by Wiley in Prenatal Diagnosis
- Vol. 13 (6), 535-537
- https://doi.org/10.1002/pd.1970130617
Abstract
Free β-HCG is a new analyte that has been suggested to be superior to total HCG when used in combination with alpha-fetoprotein (AFP) for Down syndrome risk screening in early pregnancy. We have evaluated this claim on 21 samples collected from Down syndrome pregnancies and 180 samples from unaffected pregnancies. The detection rates for the combination of AFP with free β-HCG or the combination of AFP with total HCG were identical (71 per cent) but the initial screen positive rate (equivalent to the false-positive rate) was 7·5 per cent for AFP+free β-HCG screening compared with 3·5 per cent for AFP+ total HCG screening. We conclude that the case for free β-HCG is unproven and suggest that further data be collected before free β-HCG becomes acceptable.Keywords
This publication has 5 references indexed in Scilit:
- Early Detection of Down's Syndrome Using Free Beta Human ChoriogonadotropinAnnals of Clinical Biochemistry: International Journal of Laboratory Medicine, 1992
- Evaluation of an assay of the free beta-subunit of choriogonadotropin and its potential value in screening for Down's syndromeClinical Chemistry, 1991
- Maternal serum Down syndrome screening: Free β-protein is a more effective marker than human chorionic gonadotropinAmerican Journal of Obstetrics and Gynecology, 1990
- The Mathematical Basis of Multivariate Risk Screening: With Special Reference to Screening for Down's Syndrome Associated PregnancyAnnals of Clinical Biochemistry: International Journal of Laboratory Medicine, 1990
- Maternal serum screening for Down's syndrome in early pregnancy.BMJ, 1988